COVID-19 - G2 Intelligence

Expert Q&A: Adapting to the Expanding Market of At-Home Testing

Medical director William G. Finn, MD, discusses key trends, challenges, and opportunities related to the expansion of at-home testing.

Start a Free Trial for immediate access to this article

Already a member? Log in here

Though things appeared status quo in 2023, last year may prove to be a turning point for the laboratory industry.

Start a Free Trial for immediate access to this article

Already a member? Log in here

G2’s list of major FDA approvals includes cancer and liquid biopsy, COVID-19, STI, and neurologic tests.

Start a Free Trial for immediate access to this article

Already a member? Log in here

What 2023 Q3 earnings from 30 key US lab companies indicate about the current state of the industry and outlook for 2024.

Start a Free Trial for immediate access to this article

Already a member? Log in here

Recent cases involve Medicare’s 14-Day Rule, improper PHI disclosure to a media outlet, kickbacks, and COVID-19 fraud.

Start a Free Trial for immediate access to this article

Already a member? Log in here